Is a complete IDYA research report available?

No complete published report is available for IDEAYA Biosciences, Inc. (IDYA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

IDEAYA Biosciences, Inc. (IDYA)

NASDAQ: IDYA · USD

$36.2

+1.23 (+3.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IDYA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.4B
Revenue (ttm)	225.3M
Net income (ttm)	-140.1M
EPS (ttm)	-$1.58
Shares out	95.1M
Volume	847,692
Beta	-0.09
Price target	$52.3	+44.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 225.3M
Net income (ttm): -140.1M
EPS (ttm): -$1.58
Market cap: 3.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IDYA indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001676725
Company name	IDEAYA Biosciences, Inc.
Country	United States
Country code	US
Cusip	45166A102
Employees	145
Employees Change	14%
Employees Change Percent	10.69
Enterprise value	$2.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-05-23
Isin	US45166A1025
Last refreshed	2026-07-24
Market cap	$3.4B
Market cap category	Mid-Cap
Price	$36.23
Price currency	USD
Rev Per Employee	1,553,586.21x
Sector	Healthcare
Sector PE	44.59
Sector PE Fwd	23.48
Sic	2834
Symbol	IDYA
Website	https://www.ideayabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.07%
EV Sales Forward	55.27x
EV/Sales	11.1x
FCF yield	-2.55%
P/B ratio	3.4x
P/S ratio	15.29x
PS Forward	76.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-81.44%
EBITDA Margin	-80.21%
Gross margin	-50.73%
Gross Profit	$-114.3M
Net Income	$-140.1M
Net Income Growth Years	1%
Pretax Margin	-62.17%
Profit Margin	-62.17%
Profit Per Employee	$-965,924
ROA	-10.76
Roa5y	-13.51
ROCE	-19
ROE	-14.28
Roe5y	-20.96
ROIC	-11.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	64.59%
Cagr3y	18.77%
Cagr5y	10.24%
EPS Growth Years	1
Revenue Growth	3,118.14x
Revenue Growth Years	1x
Revenue Growth3 Y	68.07x
Revenue Growth5 Y	53.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.21
Assets	$1B
Cash	$671.2M
Current Assets	$696.1M
Current Liabilities	$64.8M
Debt	$28.6M
Debt Equity	$0.03
Equity	$937.3M
Liabilities	$93.1M
Long Term Assets	$334.2M
Long Term Liabilities	$28.3M
Net Cash	$944.3M
Net Cash By Market Cap	$27.41
Net Cash Growth	-7.89%
Net Debt Equity	$-1.01
Tangible Book Value	$937.3M
Tangible Book Value Per Share	$10.67
WACC	3.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.74
Net Working Capital	$-39.6M
Quick ratio	10.45
Working Capital	$631.3M
Working Capital Turnover	$0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.21%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	64.53%
200-day SMA	32.46
3Y total return	67.58%
50-day SMA	32.6
50-day SMA vs 200-day SMA	50over200
5Y total return	62.83%
All Time High	47.74
All Time High Change	-24.1%
All Time High Date	2024-02-15
All Time Low	2.95
All Time Low Change	1,128.14%
All Time Low Date	2020-03-17
ATR	1.54
Beta	-0.09
Beta1y	0.94
Beta2y	1.3
Ch YTD	4.8
High	36.39
High52	40.58
High52 Date	2026-07-07
High52ch	-10.72%
Low	34.01
Low52	22.09
Low52 Date	2025-08-07
Low52ch	64.01%
Ma50ch	11.15%
Premarket Change Percent	-0.11
Premarket Price	$34.96
Premarket Volume	5,438
Price vs 200-day SMA	11.6%
RSI	54.61
RSI Monthly	59.15
RSI Weekly	61.43
Sharpe ratio	1.18x
Sortino ratio	1.96
Total Return	-4.21%
Tr YTD	4.8
Tr1m	5.84%
Tr1w	0.84%
Tr3m	14.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	16
Analyst Count Top	11
Analyst Price Target Top	$54.8
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.08
Earnings Revenue Estimate	7,446,270x
Operating Income	$-183.5M
Operating margin	-81.44
Price target	$52.29
Price Target Change	$44.33
Price Target Change Top	$51.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	94,236,894%
Float Percent	99.11%
Shares Insiders	0.89%
Shares Institutions	101.07%
Shares Out	95,083,145
Shares Qo Q	0.13%
Shares Yo Y	4.21%
Short Float	10.97%
Short Ratio	6.53
Short Shares	10.87

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-138.3M
Average Volume	1,158,396.85x
Bv Per Share	10.67
CAPEX	$-2M
Ch1m	5.84
Ch1w	0.84
Ch1y	64.53
Ch3m	14.4
Ch3y	67.58
Ch5y	62.83
Ch6m	0.08
Change	3.51%
Change From Open	4.41
Close	35
Days Gap	-0.86
Depreciation Amortization	2,788,000
Dollar Volume	30,711,881.2
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$-183.5M
EBITDA	$-178.9M
EPS	$-1.58
F Score	3
FCF	$-87.9M
FCF EV Yield	-3.52x
FCF Per Share	$-0.92
Financing CF	4,817,000
Fiscal Year End	December
Founded	2,015
Investing CF	109,111,000
Ipr	262.3
Iprfo	158.8
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-17
Ma150	32.76
Ma150ch	10.58%
Ma20	36.85
Ma20ch	-1.67%
Net CF	28,002,000
Next Earnings Date	2026-08-04
Open	34.7
Optionable	Yes
Position In Range	93.28
Post Close	36.23
Postmarket Change Percent	0
Postmarket Price	$36.23
Ppne	31,247,000
Pre Close	35
Price Date	2026-07-23
Ptbv Ratio	3.68
Relative Volume	0.73x
Revenue	225,270,000x
SBC By Revenue	22.38x
Share Based Comp	50,414,000
Tr6m	0.08%
Us State	California
Volume	847,692
Z Score	14.59

IDEAYA Biosciences, Inc. (IDYA)

Coverage state: Market snapshot only — no published research

Generate the first IDYA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · IDYA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IDYA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IDYA

Frequently asked questions